The onset presentation of multiple sclerosis differs in Hispanic/Latinx Americans compared with non-Hispanic White Americans.

Autor: Briggs FB; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA., Conway DS; The Mellen Center for Multiple Sclerosis and Research, Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA., Hersh CM; Lou Ruvo Center for Brain Health, Cleveland Clinic Foundation, Las Vegas, NV, USA., Fitzgerald KC; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Mowry E; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Cohen JA; The Mellen Center for Multiple Sclerosis and Research, Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA., Ontaneda D; The Mellen Center for Multiple Sclerosis and Research, Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Dec 24, pp. 13524585241304976. Date of Electronic Publication: 2024 Dec 24.

Cyrene™ as a green alternative to N , N '-dimethylformamide (DMF) in the synthesis of MLCT-emissive ruthenium(II) polypyridyl complexes for biological applications.

Autor: James SD; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Elgar CE; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Chen D; State Key Laboratory of Biotherapy, Department of Radiology and National Clinical Research Center for Geriatrics, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-Related Molecular Network, West China Hospital of Sichuan University, Sichuan University, Chengdu 610000, Sichuan Province, China. xiaohe.t@wchscu.cn., Lewis MI; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Ash ETL; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Conway DS; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Tuckley BJ; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Phillips LE; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Kolozsvári N; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Tian X; State Key Laboratory of Biotherapy, Department of Radiology and National Clinical Research Center for Geriatrics, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-Related Molecular Network, West China Hospital of Sichuan University, Sichuan University, Chengdu 610000, Sichuan Province, China. xiaohe.t@wchscu.cn., Gill MR; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk.

Publikováno v: Dalton transactions (Cambridge, England : 2003) [Dalton Trans] 2024 Nov 26; Vol. 53 (46), pp. 18506-18514. Date of Electronic Publication: 2024 Nov 26.

Neighborhood disadvantage, race, and clinical outcomes in neuromyelitis optica spectrum disorder.

Autor: Abbatemarco, JR, Aboseif, A, Swetlik, C, Widmar, J, Harvey, T, Kunchok, A, O'Mahony, J, Miller, DM, Conway, DS

Publikováno v: Multiple Sclerosis Journal; Sep2024, Vol. 30 Issue 10, p1322-1330, 9p

Neighborhood disadvantage, race, and clinical outcomes in neuromyelitis optica spectrum disorder.

Autor: Abbatemarco JR; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA., Aboseif A; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA.; Center for Multiple Sclerosis and Autoimmune Neurology, Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA., Swetlik C; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA., Widmar J; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA., Harvey T; Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, USA., Kunchok A; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA., O'Mahony J; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA., Miller DM; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA., Conway DS; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA.

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Sep; Vol. 30 (10), pp. 1322-1330. Date of Electronic Publication: 2024 Aug 06.

Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings.

Autor: Ross LA; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Lee J; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Carlson AK; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Conway DS; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Cohen JA; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Graves J; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Zamvil SS; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Newsome SD; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Kunchok A; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD.

Publikováno v: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2024 May; Vol. 11 (3), pp. e200210. Date of Electronic Publication: 2024 Feb 22.